RLFTY RELIEF THERAPEUTICS HOLDING AG
- 4.838
- +0.044+0.92%
RELIEF THERAPEUTICS HOLDING AG News
Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations
Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
Relief Therapeutics Signs Letter of Intent With Renexxion for Reverse Merger
Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment
Relief Gains as Experimental Therapy Performs on Par With BioMarin's Kuvan
Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024
Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024
Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update
Relief Therapeutics Secures up to $11 Million From Royalty Sales
6-K: Report of foreign private issuer (related to financial reporting)
Relief Therapeutics Forms New Executive Leadership Team, Names New CFO
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting
Relief Therapeutics Enters Into Exclusive U.S. License and Supply Agreement With Eton Pharmaceuticals for PKU GOLIKE
Relief Therapeutics Renews CHF 50 Million Share Subscription Facility
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
Relief Therapeutics Announces CEO Transition
No Data